<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/771B256F-5630-4ECF-A0C9-BC223CAD0DEB" ns1:id="771B256F-5630-4ECF-A0C9-BC223CAD0DEB"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/7B628F12-C172-41D6-A3B6-E8DF9A034614" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/7B628F12-C172-41D6-A3B6-E8DF9A034614" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2016-08-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/E6C9A443-67B2-4C06-925A-845FC8A16DE0" ns1:rel="FUND" ns1:start="2015-08-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">720712</ns2:identifier></ns2:identifiers><ns2:title>PROTEUS &amp;amp; SLAB next generation life science robotics for a better quality of life</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>GRD Development of Prototype</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>There were 8.2m cancer related deaths globally in 2012(1), rates are increasing &amp;gt;50% by
2020(2) &amp;amp; there are ~300K people diagnosed with cancer in the UK PA, the ~3% mortality
due to late diagnosis(3) is a major problem, equating to 10K preventable UK deaths/PA(4)
Sara Hiom (Cancer Research UK) said: &amp;quot;We know the strain the NHS is already under &amp;amp; the
number of people diagnosed with cancer is increasing - further investment is essential&amp;quot;.
Adding &amp;quot;Research would indicate we do fewer key diagnostic tests (KDT) in this country than
comparable countries, but there are a lack of workforce,… a lack of kit, to do those tests,...
this really does need to be addressed&amp;quot;(7)
KDT’s also screen for numerous long term conditions (diabetes, depression, dementia, &amp;amp;
hyper tension) which 25% (~15m) of the UK suffer from (=50% all GP consults, 70% hospital
days) ~800m KDTs/PA = ~300k patient KDTs/day
The fundamental issue affecting KDTs in the lab is cost: a small robot costs ~&amp;pound;15K for
repetitious un-skilled tasks a further &amp;pound;15K is required for software + systems integration,
making the &amp;pound;30K total purchase cost a real issue whilst valuable scientific talent carrying out
these tasks is inefficient use of resources. As in any production process, automation offers the
ability to increase efficiency, reliability, throughput &amp;amp; quality.
Existing systems are typically over-engineered for their function Our focus is creating
plug&amp;amp;play(P&amp;amp;P) hardware to automate KDT instruments &amp;amp; equipment &amp;amp; remove costly “on
site” software &amp;amp; integration Peak analysis &amp;amp; Automation Ltd (PAA) has developed a concept
with key innovations for new automation &amp;amp; integration system Our P&amp;amp;P set up is designed
specifically to address the issues at &amp;lt;1/3 total cost (&amp;pound;9K)
This system will revolutionise diagnostic testing labs in the UK &amp;amp; globally whilst offering the
opportunity to increase the quality of (&amp;amp; save) life for up to 10K UK citizens</ns2:abstractText></ns2:project>